138 related articles for article (PubMed ID: 26479144)
61. Routine versus selective cardiac magnetic resonance in non-ischemic heart failure - OUTSMART-HF: study protocol for a randomized controlled trial (IMAGE-HF (heart failure) project 1-B).
Paterson I; Wells GA; Ezekowitz JA; White JA; Friedrich MG; Mielniczuk LM; O'Meara E; Chow B; DeKemp RA; Klein R; Dennie C; Dick A; Coyle D; Dwivedi G; Rajda M; Wright GA; Laine M; Hanninen H; Larose E; Connelly KA; Leong-Poi H; Howarth AG; Davies RA; Duchesne L; Yla-Herttuala S; Saraste A; Farand P; Garrard L; Tardif JC; Arnold M; Knuuti J; Beanlands R; Chan KL
Trials; 2013 Oct; 14():332. PubMed ID: 24119686
[TBL] [Abstract][Full Text] [Related]
62. Phase I/II Study of Safety and Preliminary Efficacy of Intravenous Allogeneic Mesenchymal Stem Cells in Chronic Stroke.
Levy ML; Crawford JR; Dib N; Verkh L; Tankovich N; Cramer SC
Stroke; 2019 Oct; 50(10):2835-2841. PubMed ID: 31495331
[TBL] [Abstract][Full Text] [Related]
63. Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty.
Golpanian S; DiFede DL; Pujol MV; Lowery MH; Levis-Dusseau S; Goldstein BJ; Schulman IH; Longsomboon B; Wolf A; Khan A; Heldman AW; Goldschmidt-Clermont PJ; Hare JM
Oncotarget; 2016 Mar; 7(11):11899-912. PubMed ID: 26933813
[TBL] [Abstract][Full Text] [Related]
64. Intravenous transplantation of mesenchymal stem cells preconditioned with early phase stroke serum: current evidence and study protocol for a randomized trial.
Kim SJ; Moon GJ; Chang WH; Kim YH; Bang OY;
Trials; 2013 Oct; 14():317. PubMed ID: 24083670
[TBL] [Abstract][Full Text] [Related]
65. A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trial.
Bolli R; Mitrani RD; Hare JM; Pepine CJ; Perin EC; Willerson JT; Traverse JH; Henry TD; Yang PC; Murphy MP; March KL; Schulman IH; Ikram S; Lee DP; O'Brien C; Lima JA; Ostovaneh MR; Ambale-Venkatesh B; Lewis G; Khan A; Bacallao K; Valasaki K; Longsomboon B; Gee AP; Richman S; Taylor DA; Lai D; Sayre SL; Bettencourt J; Vojvodic RW; Cohen ML; Simpson L; Aguilar D; Loghin C; Moyé L; Ebert RF; Davis BR; Simari RD;
Eur J Heart Fail; 2021 Apr; 23(4):661-674. PubMed ID: 33811444
[TBL] [Abstract][Full Text] [Related]
66. Value of Cardiovascular Magnetic Resonance Imaging-Derived Baseline Left Ventricular Ejection Fraction and Volumes for Precise Risk Stratification of Patients With Ischemic Cardiomyopathy: Insights From the Surgical Treatment for Ischemic Heart Failure (STICH) Trial.
Pai RG; Varadarajan P; Rouleau JL; Stebbins AL; Velazquez EJ; Al-Khalidi HR; Pohost GM
JAMA Cardiol; 2017 May; 2(5):577-579. PubMed ID: 28199489
[TBL] [Abstract][Full Text] [Related]
67. Rationale and design of a prospective study to assess the effect of left cardiac sympathetic denervation in chronic heart failure.
Chin A; Ntsekhe M; Viljoen C; Rossouw J; Pennel T; Schwartz PJ
Int J Cardiol; 2017 Dec; 248():227-231. PubMed ID: 28864134
[TBL] [Abstract][Full Text] [Related]
68. OUTSMART HF: A Randomized Controlled Trial of Routine Versus Selective Cardiac Magnetic Resonance for Patients With Nonischemic Heart Failure (IMAGE-HF 1B).
Paterson DI; Wells G; Erthal F; Mielniczuk L; O'Meara E; White J; Connelly KA; Knuuti J; Radja M; Laine M; Chow BJW; Kandolin R; Chen L; Dick A; Dennie C; Garrard L; Ezekowitz J; Beanlands R; Chan KL;
Circulation; 2020 Mar; 141(10):818-827. PubMed ID: 31910649
[TBL] [Abstract][Full Text] [Related]
69. Stem cell therapy in patients with heart failure.
Vrtovec B; Poglajen G; Haddad F
Methodist Debakey Cardiovasc J; 2013; 9(1):6-10. PubMed ID: 23518819
[TBL] [Abstract][Full Text] [Related]
70. Potential Strategies for Clinical Translation of Repeated Cell Therapy.
Vrtovec B; Bolli R
Circ Res; 2019 Mar; 124(5):690-692. PubMed ID: 30817255
[TBL] [Abstract][Full Text] [Related]
71. Long-Term Results of Intracardiac Mesenchymal Stem Cell Transplantation in Patients With Cardiomyopathy.
Yagyu T; Yasuda S; Nagaya N; Doi K; Nakatani T; Satomi K; Shimizu W; Kusano K; Anzai T; Noguchi T; Ohgushi H; Kitamura S; Kangawa K; Ogawa H
Circ J; 2019 Jun; 83(7):1590-1599. PubMed ID: 31105128
[TBL] [Abstract][Full Text] [Related]
72. Mesenchymal STRO-1/STRO-3
Sundin A; Ionescu SI; Balkan W; Hare JM
Future Cardiol; 2023 Sep; 19(12):567-581. PubMed ID: 37933628
[TBL] [Abstract][Full Text] [Related]
73. Embryonic stem cell therapy of heart failure in genetic cardiomyopathy.
Yamada S; Nelson TJ; Crespo-Diaz RJ; Perez-Terzic C; Liu XK; Miki T; Seino S; Behfar A; Terzic A
Stem Cells; 2008 Oct; 26(10):2644-53. PubMed ID: 18669912
[TBL] [Abstract][Full Text] [Related]
74. Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial.
Bartunek J; Terzic A; Davison BA; Filippatos GS; Radovanovic S; Beleslin B; Merkely B; Musialek P; Wojakowski W; Andreka P; Horvath IG; Katz A; Dolatabadi D; El Nakadi B; Arandjelovic A; Edes I; Seferovic PM; Obradovic S; Vanderheyden M; Jagic N; Petrov I; Atar S; Halabi M; Gelev VL; Shochat MK; Kasprzak JD; Sanz-Ruiz R; Heyndrickx GR; Nyolczas N; Legrand V; Guédès A; Heyse A; Moccetti T; Fernandez-Aviles F; Jimenez-Quevedo P; Bayes-Genis A; Hernandez-Garcia JM; Ribichini F; Gruchala M; Waldman SA; Teerlink JR; Gersh BJ; Povsic TJ; Henry TD; Metra M; Hajjar RJ; Tendera M; Behfar A; Alexandre B; Seron A; Stough WG; Sherman W; Cotter G; Wijns W;
Eur Heart J; 2017 Mar; 38(9):648-660. PubMed ID: 28025189
[TBL] [Abstract][Full Text] [Related]
75. Rationale and design of BROKEN-SWEDEHEART: a registry-based, randomized, parallel, open-label multicenter trial to test pharmacological treatments for broken heart (takotsubo) syndrome.
Omerovic E; James S; Erlinge D; Hagström H; Venetsanos D; Henareh L; Ekenbäck C; Alfredsson J; Hambreus K; Redfors B
Am Heart J; 2023 Mar; 257():33-40. PubMed ID: 36435233
[TBL] [Abstract][Full Text] [Related]
76. Not All Stem Cells Are Created Equal.
Johnston PV; Duckers HJ; Raval AN; Cook TD; Pepine CJ
Circ Res; 2018 Sep; 123(8):944-946. PubMed ID: 30355037
[No Abstract] [Full Text] [Related]
77. Mesenchymal Stem Cell Therapy for the Treatment of Heart Failure Caused by Ischemic or Non-ischemic Cardiomyopathy: Immunosuppression and Its Implications.
Lipinski MJ; Luger D; Epstein SE
Handb Exp Pharmacol; 2017; 243():329-353. PubMed ID: 28382469
[TBL] [Abstract][Full Text] [Related]
78. Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients: The CCTRN SENECA Trial.
Bolli R; Perin EC; Willerson JT; Yang PC; Traverse JH; Henry TD; Pepine CJ; Mitrani RD; Hare JM; Murphy MP; March KL; Ikram S; Lee DP; O'Brien C; Durand JB; Miller K; Lima JA; Ostovaneh MR; Ambale-Venkatesh B; Gee AP; Richman S; Taylor DA; Sayre SL; Bettencourt J; Vojvodic RW; Cohen ML; Simpson LM; Lai D; Aguilar D; Loghin C; Moyé L; Ebert RF; Davis BR; Simari RD;
JACC CardioOncol; 2020 Nov; 2(4):581-595. PubMed ID: 33403362
[TBL] [Abstract][Full Text] [Related]
79. Impact of cannabidiol on myocardial recovery in patients with acute myocarditis: Rationale & design of the ARCHER trial.
McNamara DM; Cooper LT; Arbel Y; Bhimaraj A; Bocchi E; Friedrich MG; Kerneis M; Liu P; Parker AB; Smith ER; Tang WHW; Torre-Amione G; Tschöpe C;
ESC Heart Fail; 2024 Jun; ():. PubMed ID: 38937900
[TBL] [Abstract][Full Text] [Related]
80. [Clinical applications of cardiac magnetic resonance imaging: heart failure and cardiomyopathies].
Pedrotti P; Pedretti S; Imazio M; Quattrocchi G; Sormani P; Quarta G
G Ital Cardiol (Rome); 2018 Dec; 19(12):679-691. PubMed ID: 30520882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
